Compliance & Legal

Payers will not only need to comply with the 2024 CMS Final Rule pertaining to materials and content, but they will need to go the extra mile because it affects star ratings, says Ernie Crawford, president and CEO of Crawford Technologies.  

Joe Gagnon, CEO of 1upHealth, talks about how collaborating more on APIs can help providers generate EHR requests for information from payers.  

Among the top global policy issues at HIMSS24: AI regulation, patient access and equity. Tom Leary, SVP and head of government relations at HIMSS, explains how the organization advocates for health policies that support those goals.  

How have HIMSS24 attendees been demonstrating AI's results and discussing legislation? What strategies are there to help interoperability's progress? Robert Havasy, senior director of informatics strategy at HIMSS, answers.  

Healthcare organizations are looking for the proper use of OpenAI, research on LLMs and bias in AI technology. Harjinder Sandhu, CTO of health platforms and solutions at Microsoft, has the answers.  

With a majority of healthcare organizations lacking proper technology to address HIPAA compliance, it’s imperative that quick action is taken to avoid serious security and data privacy breaches. Our comprehensive guide provides you with all you need to know to address this time-sensitive issue.

Amazon Web Services has concerns around AI use in healthcare and regulating the technology. But it can show the benefits of AI/ML in helping life sciences firms with drug development. Dr. Jared Saul, chief medical officer at AWS, discusses the issues.

The New Jersey health system's CIDO Sunil Dadlan explains how his teams have worked to implement effective and ethical AI, and offers perspective on challenges around regulations, workforce and interoperability.

Rachini Moosavi, chief analytics officer at University of North Carolina Health, describes how and where AI is deployed at the health system – and says it plans to be ambitious in its deployments in 2024 while still being cautious.

With guidelines and rules for healthcare AI coming from the FDA, ONC, OCR, the White House and others, how will this regulatory framework change in 2024? Bryant Godfrey, partner at Foley Hoag, offers some thoughts.